HPP acted as the legal advisor on the establishment of Finnish Medicine Verification Organisation (FiMVO) Ltd, a company responsible for implementing the medicine verification system in Finland. The founding shareholders of the company are Lääketeollisuus ry, Orion Corporation, Rinnakkaislääketeollisuus ry, Suomen Lääkerinnakkaistuojat ry, Suomen Apteekkariliitto ry and Apteekkitavaratukkukauppiaat ry.
The medicine verification system is based on the requirements set out in the Falsified Medicines Directive, a directive aiming to prevent falsified medicines from entering the legal pharmaceutical supply chain and reaching patients. The verification system should be put into operation by early 2019. In addition, HPP also assists Finnish Medicine Verification Organisation (FiMVO) Ltd with questions relating to the introduction of the medicine verification system, including negotiating a delivery contract with the system vendor.